Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c00136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Rohan Kalyan Rej und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 196 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Estrogen receptor alpha (ERα) is a well-established therapeutic target for the treatment of ER-positive (ER+) breast cancers. Despite the tremendous successes achieved with tamoxifen, a selective ER modulator, and aromatase inhibitors (AIs), resistance to these therapies is a major clinical problem. Therefore, induced protein degradation and covalent inhibition have been pursued as new therapeutic approaches to target ERα. This Perspective summarizes recent progress in the discovery and development of oral selective ER degraders (SERDs), complete estrogen receptor antagonists (CERANs), selective estrogen receptor covalent antagonists (SERCAs), and proteolysis targeting chimera (PROTAC) ER degraders. We focus on those compounds which have been advanced into clinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
ORCID-Profile: Junius Eugene Thomas, Shaomeng Wang
Förderung
- National Institutes of Health
Zitieren
APA
Rej, R. K., Thomas, J. E., Acharyya, R. K., Rae, J. M., & Wang, S. (2023). Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00136
Vancouver
Rej RK, Thomas JE, Acharyya RK, Rae JM, Wang S. Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00136
BibTeX
@article{Rej2023,
author = {Rej, Rohan Kalyan and Thomas, Junius Eugene and Acharyya, Ranjan Kumar and Rae, James Michael and Wang, Shaomeng},
title = {Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c00136}
}
EUVIMED